Nomura Holdings’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.5M Sell
161,713
-94,373
-37% -$13.2M 0.06% 216
2025
Q4
$31.4M Sell
256,086
-56,166
-18% -$6.83M 0.04% 226
2025
Q3
$34.7M Buy
312,252
+155,691
+99% +$17.7M 0.05% 199
2025
Q2
$17.4M Sell
156,561
-8,475
-5% -$902K 0.04% 279
2025
Q1
$18.5M Sell
165,036
-118,478
-42% -$12.2M 0.03% 306
2024
Q4
$26.2M Buy
283,514
+53,432
+23% +$4.81M 0.04% 255
2024
Q3
$19.3M Buy
230,082
+102,628
+81% +$7.83M 0.04% 279
2024
Q2
$8.74M Buy
127,454
+94,777
+290% +$6.32M 0.02% 489
2024
Q1
$2.39M Buy
32,677
+14,274
+78% +$1.1M 0.01% 855
2023
Q4
$1.49M Buy
18,403
+9,581
+109% +$746K ﹤0.01% 1061
2023
Q3
$661K Sell
8,822
-2,576
-23% -$198K ﹤0.01% 1075
2023
Q2
$878K Sell
11,398
-6,762
-37% -$539K ﹤0.01% 938
2023
Q1
$1.51M Buy
18,160
+17,679
+3,675% +$1.46M ﹤0.01% 890
2022
Q4
$40K Buy
+481
New +$38.1K ﹤0.01% 1259
2022
Q3
Sell
-9,081
Closed -$589K 1801
2022
Q2
$589K Sell
9,081
-37,074
-80% -$2.3M ﹤0.01% 1091
2022
Q1
$2.89M Sell
46,155
-198,981
-81% -$12.7M 0.01% 782
2021
Q4
$17.9M Buy
245,136
+141,637
+137% +$9.76M 0.05% 296
2021
Q3
$7.23M Buy
103,499
+33,318
+47% +$2.34M 0.02% 507
2021
Q2
$4.92M Buy
70,181
+58,041
+478% +$3.88M 0.01% 579
2021
Q1
$808K Sell
12,140
-81,837
-87% -$5.28M ﹤0.01% 1178
2020
Q4
$5.7M Buy
93,977
+41,842
+80% +$2.52M 0.01% 550
2020
Q3
$3.43M Buy
52,135
+49,234
+1,697% +$3.41M 0.01% 547
2020
Q2
$225K Buy
+2,901
New +$222K ﹤0.01% 984
2020
Q1
Sell
-116,633
Closed -$8.06M 1039
2019
Q4
$7.63M Sell
116,633
-510,613
-81% -$33.3M 0.03% 367
2019
Q3
$40.2M Sell
627,246
-319,636
-34% -$20.9M 0.15% 114
2019
Q2
$63.7M Buy
946,882
+629,035
+198% +$41.4M 0.28% 68
2019
Q1
$20.9M Sell
317,847
-133,299
-30% -$8.86M 0.09% 179
2018
Q4
$28.4M Buy
451,146
+282,344
+167% +$19.7M 0.11% 148
2018
Q3
$13.1M Sell
168,802
-114,362
-40% -$8.64M 0.05% 307
2018
Q2
$20.1M Sell
283,164
-2,327
-0.8% -$164K 0.06% 237
2018
Q1
$21.7K Sell
285,491
-72,851
-20% -$5.79M 0.04% 236
2017
Q4
$26.1M Buy
358,342
+31,154
+10% +$2.37M 0.05% 238
2017
Q3
$26.6M Sell
327,188
-225,667
-41% -$17.3M 0.06% 201
2017
Q2
$38.7M Buy
552,855
+141,809
+34% +$9.44M 0.09% 127
2017
Q1
$27.9M Buy
411,046
+80,842
+24% +$5.68M 0.07% 129
2016
Q4
$24M Buy
330,204
+38,851
+13% +$2.89M 0.06% 194
2016
Q3
$23.1M Sell
291,353
-160,047
-35% -$13M 0.06% 154
2016
Q2
$37.9M Buy
451,400
+405,594
+885% +$36M 0.12% 87
2016
Q1
$4.18M Sell
45,806
-97,069
-68% -$8.75M 0.01% 387
2015
Q4
$14.5M Sell
142,875
-283,932
-67% -$29.5M 0.04% 185
2015
Q3
$41.7M Buy
426,807
+248,081
+139% +$27.6M 0.15% 76
2015
Q2
$20.5M Buy
178,726
+88,347
+98% +$9.65M 0.06% 152
2015
Q1
$8.79M Sell
90,379
-107,232
-54% -$10.9M 0.03% 258
2014
Q4
$18.8M Buy
197,611
+34,823
+21% +$3.6M 0.05% 228
2014
Q3
$17.1M Buy
162,788
+20,852
+15% +$2.04M 0.05% 303
2014
Q2
$11.7M Sell
141,936
-328,024
-70% -$25.5M ﹤0.01% 396
2014
Q1
$33.7M Buy
469,960
+310,347
+194% +$24.3M 0.01% 192
2013
Q4
$12M Sell
159,613
-177,020
-53% -$12.3M 0.05% 202
2013
Q3
$21.2M Sell
336,633
-23,469
-7% -$1.4M 0.13% 123
2013
Q2
$18.5M Buy
+360,102
New +$18.8M 0.15% 105

Other funds holding GILD

Nomura Holdings's GILD Position: Q1 2026 in Review

Nomura Holdings reduced its Gilead Sciences (GILD) stake by 37% in Q1 2026, selling an estimated $13.2M and leaving 161,713 shares worth $22.5M. The position accounts for 0.06% of the portfolio, ranked #216.

Nomura Holdings first reported a position in GILD in Q2 2013 and has held it in 50 quarters since. The position peaked at $63.7M in Q2 2019. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Nomura Holdings held 161,713 shares of Gilead Sciences worth $22.5M as of Q1 2026.
  • Nomura Holdings sold 94,373 Gilead Sciences shares in Q1 2026, an estimated $13.2M.
  • Gilead Sciences made up 0.06% of Nomura Holdings's portfolio in Q1 2026, its #216 holding.
  • Nomura Holdings first reported a position in Gilead Sciences in Q2 2013 and has held it in 50 quarters since.
  • Nomura Holdings's Gilead Sciences position peaked at $63.7M in Q2 2019.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.